Zentalis Pharmaceuticals, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Zentalis Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2019 to 2023.
  • Zentalis Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $7K.
  • Zentalis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $237M, a 9.09% decline from 2022.
  • Zentalis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $261M, a 46.2% increase from 2021.
  • Zentalis Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $179M, a 50.5% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $237M -$23.7M -9.09% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $261M +$82.5M +46.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $179M -$182M -50.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $360M +$279M +340% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $81.8M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.